Published in J Virol on January 01, 1981
Rotavirus gene structure and function. Microbiol Rev (1989) 6.95
Production and preliminary characterization of monoclonal antibodies directed at two surface proteins of rhesus rotavirus. J Virol (1983) 5.44
Proteolytic enhancement of rotavirus infectivity: molecular mechanisms. J Virol (1981) 4.87
Sequence of the fourth gene of human rotaviruses recovered from asymptomatic or symptomatic infections. J Virol (1988) 3.20
Infectious rotavirus enters cells by direct cell membrane penetration, not by endocytosis. J Virol (1988) 2.72
Human viral gastroenteritis. Microbiol Rev (1984) 2.70
Identification, synthesis, and modifications of simian rotavirus SA11 polypeptides in infected cells. J Virol (1982) 2.67
Cross-reactive neutralization epitopes on VP3 of human rotavirus: analysis with monoclonal antibodies and antigenic variants. J Virol (1987) 2.51
Purification and characterization of bovine rotavirus cores. J Virol (1982) 2.43
Conservation of amino acid sequence of VP8 and cleavage region of 84-kDa outer capsid protein among rotaviruses recovered from asymptomatic neonatal infection. Proc Natl Acad Sci U S A (1986) 2.37
Sequence diversity of human rotavirus strains investigated by northern blot hybridization analysis. J Virol (1982) 2.34
Trypsin enhancement of rotavirus infectivity: mechanism of enhancement. J Virol (1981) 2.29
Functional and topographical analyses of epitopes on the hemagglutinin (VP4) of the simian rotavirus SA11. J Virol (1988) 2.08
Gene protein products of SA11 simian rotavirus genome. J Virol (1982) 2.07
Characterization of a human pararotavirus. Infect Immun (1984) 1.93
Biochemical mapping of the simian rotavirus SA11 genome. J Virol (1983) 1.88
Integrins alpha2beta1 and alpha4beta1 can mediate SA11 rotavirus attachment and entry into cells. J Virol (2000) 1.72
Complete nucleotide sequence of the gene encoding VP4 of a human rotavirus (strain K8) which has unique VP4 neutralization epitopes. J Virol (1989) 1.71
Trypsin activation pathway of rotavirus infectivity. J Virol (1996) 1.63
Binding to sialic acids is not an essential step for the entry of animal rotaviruses to epithelial cells in culture. J Virol (1993) 1.50
Serotype-specific epitope(s) present on the VP8 subunit of rotavirus VP4 protein. J Virol (1991) 1.47
Initial interaction of rotavirus strains with N-acetylneuraminic (sialic) acid residues on the cell surface correlates with VP4 genotype, not species of origin. J Virol (2002) 1.42
Rotavirus capsid protein VP5* permeabilizes membranes. J Virol (1999) 1.42
Molecular and antigenic characterization of porcine rotavirus YM, a possible new rotavirus serotype. J Virol (1988) 1.38
Rotaviruses induce an early membrane permeabilization of MA104 cells and do not require a low intracellular Ca2+ concentration to initiate their replication cycle. J Virol (1997) 1.32
Role of sialic acids in rotavirus infection. Glycoconj J (2006) 1.28
Cleavage of rhesus rotavirus VP4 after arginine 247 is essential for rotavirus-like particle-induced fusion from without. J Virol (1998) 1.27
The amino-terminal half of rotavirus SA114fM VP4 protein contains a hemagglutination domain and primes for neutralizing antibodies to the virus. J Virol (1991) 1.25
Effect of tunicamycin on rotavirus assembly and infectivity. J Virol (1982) 1.23
Neutralization epitopes on rotavirus SA11 4fM outer capsid proteins. J Virol (1990) 1.20
The effects of midgut serine proteases on dengue virus type 2 infectivity of Aedes aegypti. Am J Trop Med Hyg (2008) 1.17
Bluetongue virus: dissection of the polymerase complex. J Gen Virol (2008) 1.17
The VP5 domain of VP4 can mediate attachment of rotaviruses to cells. J Virol (2000) 1.16
Comparisons of rotavirus polypeptides by limited proteolysis: close similarity of certain polypeptides of different strains. J Virol (1981) 1.11
Rotavirus YM gene 4: analysis of its deduced amino acid sequence and prediction of the secondary structure of the VP4 protein. J Virol (1991) 1.09
Association of viral particles and viral proteins with membranes in SA11-infected cells. J Virol (1982) 1.09
NS35 and not vp7 is the soluble rotavirus protein which binds to target cells. J Virol (1990) 1.08
Virus-like particle-induced fusion from without in tissue culture cells: role of outer-layer proteins VP4 and VP7. J Virol (1997) 1.07
Different rotavirus strains enter MA104 cells through different endocytic pathways: the role of clathrin-mediated endocytosis. J Virol (2010) 1.06
Rotavirus spike structure and polypeptide composition. J Virol (1991) 1.03
Inhibition of rotaviruses by selected antiviral substances: mechanisms of viral inhibition and in vivo activity. Antimicrob Agents Chemother (1982) 1.01
Analysis of host range restriction determinants in the rabbit model: comparison of homologous and heterologous rotavirus infections. J Virol (1998) 1.01
Identification of a type 1 peroxisomal targeting signal in a viral protein and demonstration of its targeting to the organelle. J Virol (2002) 1.01
Identification of a T-helper cell epitope on the rotavirus VP6 protein. J Virol (1997) 1.00
Attachment and growth of human rotaviruses RV-3 and S12/85 in Caco-2 cells depend on VP4. J Virol (1998) 0.98
Synthesis of plus- and minus-strand RNA in rotavirus-infected cells. J Virol (1987) 0.96
Monkey rotavirus binding to alpha2beta1 integrin requires the alpha2 I domain and is facilitated by the homologous beta1 subunit. J Virol (2003) 0.93
Effects on rotavirus cell binding and infection of monomeric and polymeric peptides containing alpha2beta1 and alphaxbeta2 integrin ligand sequences. J Virol (2004) 0.91
Viruses and cells with mutations affecting viral entry are selected during persistent rotavirus infections of MA104 cells. J Virol (1998) 0.91
The spike protein VP4 defines the endocytic pathway used by rotavirus to enter MA104 cells. J Virol (2012) 0.91
A synthetic peptide corresponding to the cleavage region of VP3 from rotavirus SA11 induces neutralizing antibodies. J Virol (1988) 0.90
Discrete domains within the rotavirus VP5* direct peripheral membrane association and membrane permeability. J Virol (2004) 0.89
Rotaviruses reach late endosomes and require the cation-dependent mannose-6-phosphate receptor and the activity of cathepsin proteases to enter the cell. J Virol (2014) 0.88
Human rotavirus K8 strain represents a new VP4 serotype. J Virol (1993) 0.87
Priming for rotavirus neutralizing antibodies by a VP4 protein-derived synthetic peptide. J Virol (1989) 0.87
In vitro transcription of human pararotavirus. J Virol (1986) 0.86
Characterization of full-length and polymerase chain reaction-derived partial-length Gottfried and OSU gene 4 probes for serotypic differentiation of porcine rotaviruses. J Clin Microbiol (1992) 0.86
Antigenic and genetic analyses of human rotavirus with dual subgroup specificity. J Clin Microbiol (1990) 0.85
Enhancement of aquareovirus infectivity by treatment with proteases: mechanism of action. J Virol (1998) 0.85
VP7 mediates the interaction of rotaviruses with integrin alphavbeta3 through a novel integrin-binding site. J Virol (2004) 0.84
Oral vaccination with the porcine rotavirus VP4 outer capsid protein expressed by Lactococcus lactis induces specific antibody production. J Biomed Biotechnol (2010) 0.81
Cross-linking of rotavirus outer capsid protein VP7 by antibodies or disulfides inhibits viral entry. J Virol (2011) 0.81
Characterization of neuraminidase-resistant mutants derived from rotavirus porcine strain OSU. J Virol (2005) 0.79
Structural correlates of rotavirus cell entry. PLoS Pathog (2014) 0.78
Identification of Equine Lactadherin-derived Peptides That Inhibit Rotavirus Infection via Integrin Receptor Competition. J Biol Chem (2015) 0.77
Expression of the OSU rotavirus outer capsid protein VP4 by an adenovirus recombinant. J Virol (1992) 0.75
Modeling of the rotavirus group C capsid predicts a surface topology distinct from other rotavirus species. Virology (2015) 0.75
Isolation and identification of group A rotaviruses among neonatal diarrheic calves, Morocco. BMC Res Notes (2016) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels. Eur J Biochem (1974) 113.22
Peptide mapping by limited proteolysis in sodium dodecyl sulfate and analysis by gel electrophoresis. J Biol Chem (1977) 72.51
The role of viral glycoproteins in adsorption, penetration, and pathogenicity of viruses. Rev Infect Dis (1980) 4.61
In vitro transcription and translation of simian rotavirus SA11 gene products. J Virol (1980) 4.40
Biochemical and biophysical characteristics of diarrhea viruses of human and calf origin. J Virol (1975) 4.06
Activation of rotavirus RNA polymerase by calcium chelation. Arch Virol (1979) 3.44
Shift in the prevalent human rotavirus detected by ribonucleic acid segment differences. Infect Immun (1980) 3.34
Coding assignments of double-stranded RNA segments of SA 11 rotavirus established by in vitro translation. J Virol (1980) 3.10
Rotavirus isolation and cultivation in the presence of trypsin. J Clin Microbiol (1977) 2.99
Further biochemical characterization, including the detection of surface glycoproteins, of human, calf, and simian rotaviruses. J Virol (1977) 2.60
Cell culture propagation of porcine rotavirus (reovirus-like agent). Am J Vet Res (1977) 2.51
Rotavirus polypeptides. J Gen Virol (1979) 2.23
Characterisation of a rotavirus.20b. Nature (1975) 2.21
The effect of trypsin on the growth of rotavirus. J Gen Virol (1978) 1.86
Polypeptides of bovine rotavirus. J Gen Virol (1979) 1.85
Proteolytic enhancement of rotavirus infectivity: biology mechanism. Virology (1980) 1.81
Effect of enzymes on rotavirus infectivity. J Clin Microbiol (1979) 1.79
Biochemical studies on a reovirus-like agent (rotovirus) from lambs. J Virol (1977) 1.67
Biochemical characterization of infantile gastroenteritis virus (IGV). J Gen Virol (1977) 1.56
Polypeptides of simian rotavirus (SA-11) determined by a continuous polyacrylamide gel electrophoresis method. J Gen Virol (1979) 1.36
A simple immunofluorescent technique for the detection of human rotavirus. J Med Virol (1979) 1.35
STUDIES ON THE STRUCTURE OF VIRUSES OF THE COLUMBIA SK GROUP. II. THE PROTEIN SUBUNITS OF ME-VIRUS AND OTHER MEMBERS OF THE COLUMBIA SK GROUP. Virology (1965) 1.26
DNA of bacteriophage PM2: a closed circular double-stranded molecule. Proc Natl Acad Sci U S A (1969) 6.47
Properties of bacteriophage PM2: a lipid-containing bacterial virus. Virology (1968) 5.81
Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. J Comp Neurol (2000) 4.17
The melanin-concentrating hormone system of the rat brain: an immuno- and hybridization histochemical characterization. J Comp Neurol (1992) 3.53
Shift in the prevalent human rotavirus detected by ribonucleic acid segment differences. Infect Immun (1980) 3.34
Distinctive ribonucleic acid patterns of human rotavirus subgroups 1 and 2. Infect Immun (1981) 3.13
Presence of two distinct types of rotavirus in infants and young children hospitalized with acute gastroenteritis in Mexico City, 1977. J Infect Dis (1979) 2.84
Primary structure of the cleavage site associated with trypsin enhancement of rotavirus SA11 infectivity. Virology (1985) 2.63
Distinct reovirus-like agents associated with acute infantile gastroenteritis. J Clin Microbiol (1977) 2.14
Gene protein products of SA11 simian rotavirus genome. J Virol (1982) 2.07
Characterization of a human pararotavirus. Infect Immun (1984) 1.93
Diversity of rotavirus serotypes in Mexican infants with gastroenteritis. J Clin Microbiol (1990) 1.85
Transgenic mice with inducible dwarfism. Nature (1989) 1.84
Replication of bacteriophage PM2 deoxyribonucleic acid: a closed circular double-stranded molecule. J Mol Biol (1971) 1.72
Trypsin activation pathway of rotavirus infectivity. J Virol (1996) 1.63
Urocortin expression in rat brain: evidence against a pervasive relationship of urocortin-containing projections with targets bearing type 2 CRF receptors. J Comp Neurol (1999) 1.57
Integrin alpha(v)beta(3) mediates rotavirus cell entry. Proc Natl Acad Sci U S A (2000) 1.56
Somatotroph hypoplasia and dwarfism in transgenic mice expressing a non-phosphorylatable CREB mutant. Nature (1991) 1.55
Biochemical characterization of rotavirus receptors in MA104 cells. J Virol (2000) 1.52
Ceramic femoral head fractures in total hip replacement. Int Orthop (1999) 1.51
Binding to sialic acids is not an essential step for the entry of animal rotaviruses to epithelial cells in culture. J Virol (1993) 1.50
Ultrastructure of bacterial cells infected with bacteriophage PM2, a lipid-containing bacterial virus. J Virol (1968) 1.49
Sequence analysis of two mutants of Sindbis virus defective in the intracellular transport of their glycoproteins. J Mol Biol (1983) 1.45
A simple electrophoretic method for the determination of superhelix density of closed circular DNAs and for observation of their superhelix density heterogeneity. Anal Biochem (1976) 1.39
Molecular and antigenic characterization of porcine rotavirus YM, a possible new rotavirus serotype. J Virol (1988) 1.38
Conservation in rotaviruses of the protein region containing the two sites associated with trypsin enhancement of infectivity. Virology (1986) 1.38
Rotaviruses induce an early membrane permeabilization of MA104 cells and do not require a low intracellular Ca2+ concentration to initiate their replication cycle. J Virol (1997) 1.32
Properties and characterization of the host bacterium of bacteriophage PM2. J Bacteriol (1968) 1.30
Characteristics of Streptococcus bovis endocarditis and its differences with Streptococcus viridans endocarditis. Eur J Clin Microbiol Infect Dis (2008) 1.30
Primary structure of the neutralization antigen of simian rotavirus SA11 as deduced from cDNA sequence. J Virol (1984) 1.27
Penetration of Listeria monocytogenes in mice infected by the oral route. Microb Pathog (1997) 1.27
The amino-terminal half of rotavirus SA114fM VP4 protein contains a hemagglutination domain and primes for neutralizing antibodies to the virus. J Virol (1991) 1.25
Entry of rotaviruses is a multistep process. Virology (1999) 1.25
Evidence for an intramedullary prostaglandin-dependent mechanism in the activation of stress-related neuroendocrine circuitry by intravenous interleukin-1. J Neurosci (1997) 1.24
Comparison of human rotaviruses isolated in Mexico City and in Santiago, Chile, by electrophoretic migration of their double-stranded ribonucleic acid genome segments. Infect Immun (1980) 1.24
Inhibitory effects of human and bovine milk constituents on rotavirus infections. J Dairy Sci (2004) 1.23
Relative localization of viroplasmic and endoplasmic reticulum-resident rotavirus proteins in infected cells. Arch Virol (2000) 1.22
Interactions between the two surface proteins of rotavirus may alter the receptor-binding specificity of the virus. J Virol (1996) 1.22
Synthesis in Escherichia coli and immunological characterization of a polypeptide containing the cleavage sites associated with trypsin enhancement of rotavirus SA11 infectivity. J Gen Virol (1987) 1.21
Bacterial populations in samples of bioleached copper ore as revealed by analysis of DNA obtained before and after cultivation. Appl Environ Microbiol (1996) 1.20
Distribution of the EP3 prostaglandin E(2) receptor subtype in the rat brain: relationship to sites of interleukin-1-induced cellular responsiveness. J Comp Neurol (2000) 1.19
The VP5 domain of VP4 can mediate attachment of rotaviruses to cells. J Virol (2000) 1.16
Integrin alpha2beta1 mediates the cell attachment of the rotavirus neuraminidase-resistant variant nar3. Virology (2000) 1.16
Different polypeptide composition of two human rotavirus types. Infect Immun (1980) 1.14
Diagnosis of retained abdominal gauze swabs. Br J Surg (1995) 1.14
Molecular analysis of microbiota along the digestive tract of juvenile Atlantic salmon (Salmo salar L.). Microb Ecol (2008) 1.12
Bacterial 16S rRNA gene analysis revealed that bacteria related to Arcobacter spp. constitute an abundant and common component of the oyster microbiota (Tiostrea chilensis). Microb Ecol (2002) 1.11
In vivo interactions among rotavirus nonstructural proteins. Arch Virol (1998) 1.11
Propionate precursors and other metabolic intermediates as possible alternative electron acceptors to methanogenesis in ruminal fermentation in vitro. Br J Nutr (2005) 1.10
Identification of two independent neutralization domains on the VP4 trypsin cleavage products VP5* and VP8* of human rotavirus ST3. Virology (1995) 1.09
The C-terminal domain of rotavirus NSP5 is essential for its multimerization, hyperphosphorylation and interaction with NSP6. J Gen Virol (2000) 1.09
Association of viral particles and viral proteins with membranes in SA11-infected cells. J Virol (1982) 1.09
A community outbreak of Legionnaires' disease associated with a cooling tower in Vic and Gurb, Catalonia (Spain) in 2005. Eur J Clin Microbiol Infect Dis (2008) 1.08
Mapping the hemagglutination domain of rotaviruses. J Virol (1995) 1.07
The nucleotide sequence of the 5' and 3' ends of rotavirus SA11 gene 4. Nucleic Acids Res (1987) 1.06
Enterocytozoon bieneusi (microsporidia) in faecal samples from domestic animals from Galicia, Spain. Mem Inst Oswaldo Cruz (2002) 1.05
Functional and structural analysis of the sialic acid-binding domain of rotaviruses. J Virol (1997) 1.02
Seasonal idiopathic rhinitis with local inflammatory response and specific IgE in absence of systemic response. Allergy (2008) 1.02
Fast-muscle-specific DNA-protein interactions occurring in vivo at the human aldolase A M promoter are necessary for correct promoter activity in transgenic mice. Mol Cell Biol (1996) 1.01
Prognostic factors in paediatric acute liver failure. Arch Dis Child (2007) 1.01
Diversity of Flavobacterium psychrophilum and the potential use of its phages for protection against bacterial cold water disease in salmonids. J Fish Dis (2012) 0.97
Effect of metabolic conditions on protein turnover in yeast. Biochem J (1979) 0.96
Follow-up study in head and neck cancer: cure rate according to tumor location and stage. Oncology (1997) 0.96
Antigenic and genomic diversity of human rotavirus VP4 in two consecutive epidemic seasons in Mexico. J Clin Microbiol (1998) 0.95
The Pit-1 gene is regulated by distinct early and late pituitary-specific enhancers. Dev Biol (1997) 0.92
Cytokine and chemokine expression in the skin from patients with maculopapular exanthema to drugs. Allergy (2008) 0.92
Shifts in the electrophoretic pattern on the RNA genome of rotaviruses under different electrophoretic conditions. J Virol Methods (1984) 0.91
The DNA of bacteriophage PM 2. Ultracentrifugal evidence for a circular structure. Virology (1969) 0.91
The internal rotavirus protein VP6 primes for an enhanced neutralizing antibody response. Arch Virol (2000) 0.91
P-selectin expression and Kupffer cell activation in rat acute pancreatitis. Dig Dis Sci (2000) 0.91
Inhibin beta, somatostatin, and enkephalin immunoreactivities coexist in caudal medullary neurons that project to the paraventricular nucleus of the hypothalamus. J Comp Neurol (1990) 0.90
Binding of lanthanum ions and ruthenium red to synaptosomes and its effects on neurotransmitter release. J Neurochem (1985) 0.90
Further antigenic characterization of porcine rotavirus YM. J Clin Microbiol (1989) 0.89
Regulation of inducible nitric oxide synthase expression in rat mesangial cells and isolated glomeruli. Kidney Int (1995) 0.89
Heterogeneity in base sequence among different DNA clones containing equivalent sequences of rotavirus double-stranded RNA. J Virol (1986) 0.87
Lymph nodes and human tumors (review). Int J Mol Med (1998) 0.87
A neuropsychological assessment of frontal cognitive functions in Prader-Willi syndrome. J Intellect Disabil Res (2007) 0.87
Repeated oral dosing with Listeria monocytogenes in mice as a model of central nervous system listeriosis in man. J Comp Pathol (1999) 0.87
Genomic rearrangements in human rotavirus strain Wa; analysis of rearranged RNA segment 7. Arch Virol (1992) 0.87
Evaluation of three methodologies to estimate the VO2max in people of different ages. Appl Ergon (2010) 0.87
Immunological characterization of a rotavirus-neutralizing epitope fused to the cholera toxin B subunit. Gene (1993) 0.86
[Diaphysary tubular stenosis (Kenny-Caffey's syndrome): presentation of four observations (author's transl)]. An Esp Pediatr (1980) 0.86
Serotype specificity of the neutralizing-antibody response induced by the individual surface proteins of rotavirus in natural infections of young children. Clin Diagn Lab Immunol (1998) 0.86
Prolonged persistence of Listeria monocytogenes after intragastric infection in corticosteroid-treated mice. Vet Microbiol (1997) 0.85
Release of progeny virus from cells infected with simian rotavirus SA11. J Gen Virol (1985) 0.85
Heterogeneity of VP4 neutralization epitopes among serotype P1A human rotavirus strains. Clin Diagn Lab Immunol (1995) 0.85
Early events of rotavirus infection: the search for the receptor(s). Novartis Found Symp (2001) 0.85
Chemolithotrophic bacteria in copper ores leached at high sulfuric Acid concentration. Appl Environ Microbiol (1997) 0.84
Bacterial community in copper sulfide ores inoculated and leached with solution from a commercial-scale copper leaching plant. Appl Environ Microbiol (1997) 0.84
Community outbreak of Legionnaires disease in Vic-Gurb, Spain in October and November 2005. Euro Surveill (2007) 0.84
Parasitic infections in mixed system-based heliciculture farms: dynamics and key epidemiological factors. Parasitology (2013) 0.84
Differential effects of COX inhibitors against beta-amyloid-induced neurotoxicity in human neuroblastoma cells. Neurochem Int (2005) 0.83
Ultrastructural localization of the corticotropin-releasing factor-binding protein in rat brain and pituitary. J Comp Neurol (1999) 0.83
Origin of phospholipid in bacteriophage PM2. J Virol (1968) 0.83
[Excess mortality due to tuberculosis and factors associated to death in and annual cohort of patients diagnosed of tuberculosis]. Rev Clin Esp (2006) 0.83